Electromed ( (ELMD) ) has issued an update.
On March 6, 2025, Electromed’s board of directors authorized a new share repurchase program, allowing the company to buy back up to $5.0 million of its common stock. This move, announced on March 10, 2025, reflects the company’s confidence in its business strength and aims to enhance shareholder value by utilizing excess cash reserves for stock repurchases, while maintaining financial flexibility for future growth.
More about Electromed
Electromed, Inc., headquartered in New Prague, Minnesota, is a company that manufactures, markets, and sells airway clearance therapy products, including the SmartVest® Airway Clearance System, catering to patients with compromised pulmonary function. Founded in 1992, Electromed focuses on innovative solutions in the medical device industry.
YTD Price Performance: -15.51%
Average Trading Volume: 104,525
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $217.6M
See more insights into ELMD stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com